Results 1 to 10 of about 51,509 (201)
Journal of Pharmacy and Bioallied Sciences, 2012 Bisphosphonates are used widely for variety of bone condition, most notably IV bisphosphonates in the treatment of metastic bone lesion and oral bisphosphonates for osteoporosis.
Nalliappan Ganapathy +4 more
doaj +4 more sources
Endocrinology and Metabolism Clinics of North America, 2003 Osteoporosis is the result of bone loss due to an imbalance in bone turnover such that bone resorption exceeds bone formation. Bisphosphonates are potent inhibitors of osteoclast activity that reduce bone turnover and re-establish the balance between bone resorption and formation. In clinical studies, several bisphosphonates prevent bone loss, preserve
Julie T, Lin, Joseph M, Lane
openaire +7 more sources
Bisphosphonates for Osteoporosis [PDF]
New England Journal of Medicine, 2011 One in three women and at least one in 12 men in the UK have osteoporosis, a condition which can lead to fractures, deformity, pain and disability, at a cost to the NHS of around £1.5 billion each year.1,2 Bisphosphonates offer a therapeutic option for preventing and treating osteoporosis.
Vis, M., Dijkmans, B.A.C., Lems, W.F.
+9 more sources
Frontiers in Chemistry, 2022 Phosphonates and bisphosphonates are stable analogs of phosphates and pyrophosphates that are characterized by one and two carbon–phosphorus bonds, respectively.
Babak Kaboudin +3 more
doaj +1 more source
Journal of Orthopaedic Translation, 2020 Objective: The objective of this study was to assess the efficacy and safety of denosumab therapy in osteoporotic postmenopausal women who were previously treated with bisphosphonates. Methods: Meta-analyses of four available randomised controlled trials
Yilin Zhu +9 more
doaj +1 more source
Therapeutic Advances in Chronic Disease, 2022 Background: Bisphosphonates are a type of medication that prevents the loss of bone density. Secondary childhood osteoporosis reduces bone strength and results in an increased risk of fragility fracture.
Huawei Zhao +5 more
doaj +1 more source
Atypical femur fractures associated with chronic bisphosphonates use: A case series with 66 patients [PDF]
Revista Brasileira de Ortopedia, 2022 Objective The present study aims to describe outcomes from a series of surgically treated patients with atypical femoral fracture due to bisphosphonates use, in addition to correlate the time of previous medication use with fracture consolidation time ...
Guilherme Guadagnini Falotico +5 more
doaj +1 more source
eJournal of Oral Maxillofacial Research, 2023 Objectives: The aim of this cross-sectional study is to evaluate Lithuanian fourth- and fifth-year dental students' knowledge about bisphosphonates and bisphosphonate-related osteonecrosis of the jaw. Material and Methods: The anonymous survey using a
Greta Sereikaite +4 more
doaj +1 more source
Bisphosphonates and Cancer [PDF]
Journal of Veterinary Internal Medicine, 2004 Abstract Bisphosphonates form a family of drugs characterized pharmacologically by their ability to inhibit bone resorption and pharma-cokinetically by similar intestinal absorption, skeletal distribution, and renal elimination. Two groups of bisphosphonates exist chemically, non-amino-bisphosphates and amino-bisphosphonates.
Rowan J, Milner +5 more
openaire +2 more sources
Bisphosphonates Target B Cells to Enhance Humoral Immune Responses
Cell Reports, 2013 Bisphosphonates are a class of drugs that are widely used to inhibit loss of bone mass in patients. We show here that the administration of clinically relevant doses of bisphosphonates in mice increases antibody responses to live and inactive viruses ...
Elena Tonti +14 more
doaj +1 more source